TRETINOIN
| Brand name | ALTRENO |
|---|---|
| Active ingredient | TRETINOIN |
| Strength | 0.05% |
| Dosage form | LOTION |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | August 2018 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10653656 | August 2038 | product |
| 11324710 | August 2038 | use U-2368 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.